Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Alpha lipoic acid (ALA) is a powerful antioxidant often recommended by doctors as a complement to diet and exercise for people with diabetes. It works by improving insulin sensitivity, neutralizing oxidative stress, and helping stabilize blood sugar levels, which may also protect against diabetic nerve damage (neuropathy).
Before starting ALA, it's important to understand the proper dosage, safety considerations, and potential interactions with medications like insulin or thyroid drugs. Talking with your doctor is the safest first step.
If you're experiencing symptoms like tingling, numbness, fatigue, or unstable blood sugar, don't guess what's happening. Take a free, instant, online symptom check to better understand your symptoms, identify possible causes, and confidently navigate your next steps with personalized guidance.
Reviewed for medical accuracy: 06/22/2026
Managing blood sugar can feel like a juggling act. Alongside diet, exercise and prescription medications, your doctor may suggest a supplement called alpha lipoic acid (ALA). Backed by decades of research and clinical trials, ALA offers unique benefits for people with diabetes or prediabetes. Here's what you need to know.
Alpha lipoic acid (ALA) is a naturally occurring compound found inside every cell of the body. It helps turn glucose (sugar) into energy and acts as a powerful antioxidant.
Your doctor's recommendation is rooted in two main actions of ALA:
Improved insulin sensitivity
Oxidative stress reduction
Clinical studies have highlighted several ways ALA can support diabetes management:
Insulin Sensitivity Trials
A review in Diabetes Care (2001) found that 600 mg of ALA daily improved insulin sensitivity by as much as 27% in people with type 2 diabetes.
Neuropathy Studies
A meta-analysis in the Journal of Diabetes and Its Complications (2016) reported that ALA at doses of 600–1,800 mg/day reduced neuropathic symptoms by up to 50% over 5 weeks.
Oxidative Stress Markers
Research published in Free Radical Biology and Medicine (2012) showed significant decreases in oxidative stress markers after 4 weeks of ALA supplementation.
Long-Term Outcomes
In the SYDNEY 2 trial, 600 mg ALA daily for 5 weeks not only relieved neuropathy symptoms but also improved nerve conduction velocity, suggesting lasting nerve health benefits.
Bottom line: Decades of studies support ALA's role in improving insulin action, protecting nerves and reducing oxidative damage.
Your doctor will tailor the dose based on your individual needs, but common guidelines include:
Before starting ALA, discuss the following with your doctor:
If you're curious whether ALA could fit into your blood sugar management plan:
Alpha lipoic acid is safe for most people, but if you experience any of the following, seek medical attention right away:
Alpha lipoic acid has earned its place as a complementary option for blood sugar management and diabetic neuropathy relief. By improving insulin sensitivity and cutting oxidative stress, ALA addresses two core challenges of diabetes care. If you're interested in adding this supplement to your regimen, speak with your doctor to determine the right dose and monitor your response. Always prioritize professional medical advice for anything that could be life-threatening or seriously impact your health.
(References)
* Li G, et al. Alpha-lipoic acid in the treatment of type 2 diabetes: a meta-analysis of randomized controlled trials. Biomed Pharmacother. 2018 Sep;105:1022-1029. PMID: 29979921.
* Rochette L, et al. Alpha-lipoic acid (ALA) as a potential therapeutic agent for diabetes and its complications. Curr Med Chem. 2018;25(10):1134-1144. PMID: 29199990.
* Ponnusamy S, et al. Alpha-lipoic acid and diabetes: an updated systematic review and meta-analysis of the clinical evidence. J Diabetes Complications. 2020 Jul;34(7):107590. PMID: 32448439.
* Wang X, et al. Effects of alpha-lipoic acid on glycemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes Complications. 2019 Mar;33(3):218-228. PMID: 30658933.
* Akbari M, et al. The Effects of Alpha-Lipoic Acid Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Nutr. 2021 May-Jun;40(4):371-383. PMID: 32679269.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.